Wir verwenden Cookies, um zu verstehen, wie Sie unsere Website nutzen, und um die Benutzerfreundlichkeit zu verbessern. Dies beinhaltet die Personalisierung von Inhalten und Werbung. Mit der weiteren Nutzung unserer Seite akzeptieren Sie die Verwendung von Cookies, die Datenschutzrichtlinie und die Nutzungsbedingungen Cookies, Privacy Policy Term of use.
Video Player is loading.
Current Time 0:02
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
23,286 views • December 17, 2021

Live Q&A: CDC May Limit J&J Vaccine Over Complications; Hospitals Get Incentives On COVID Treatments

The CDC is considering whether it should stop use of the Johnson & Johnson COVID-19 vaccine over cases of it causing blood clots, which have been seen more in young and middle aged women. The Washington Post reports that “the Advisory Committee on Immunization Practices will be presented with new data that appears to show the rate of the clots in people who received the Johnson & Johnson shot has increased since April, although the problem is still rare.” In other news, a report from the Association of American Physicians and Surgeons details how hospitals get incentive payments for patients of COVID-19, and details how these incentives could limit patient care and possibly harm patients. It states, “The CARES Act provides incentives for hospitals to use treatments dictated solely by the federal government under the auspices of the NIH. These ‘bounties’ must be paid back if not “earned” by making the COVID-19 diagnosis and following the COVID-19 protocol.” In this live Q&A with Crossroads host Joshua Philipp, we’ll discuss these stories and others, and answer questions from the audience.
Show All
Comment 0